1. Thomas C, Karagounis I, Srivastava RK, Vrettos N, Nikolos F, Francois N, Huang M, Gong S, Long Q, Kumar S, Koumenis C, Krishnamurthy S, Ueno NT, Chakrabarti R, Maity A (2021). Estrogen receptor β-mediated inhibition of actin-based cell migration suppresses metastasis of inflammatory breast cancer. Cancer Research, January 29 2021, DOI:10.1158/0008-5472.CAN-20-2743.
  2. Bado I, Nikolos F, Rajapaksa G, Wu W, Castaneda J, Krishnamurthy S, Webb P, Gustafsson JÅ Thomas C (2017) Somatic loss of ERβ and p53 synergize to induce breast tumorigenesis. Breast Cancer Res, 19:79 DOI:10.1186/s13058-017-0872-z.
  3. Rajapaksa G, Nikolos F, Bado I, Clarke R, Gustafsson JÅ, Thomas C (2015) ERβ decreases breast cancer cell survival by regulating the IRE1/XBP-1 pathway. Oncogene 34(31): 4130-41.
  4. Thomas C, Gustafsson JA (2011). The different roles of ER subtypes in cancer biology and therapy. Nat Rev Cancer 11: 597-608.